- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
I underwent general training in clinical & laboratory haematology in the West Midlands and the Bristol/Bath area. In the middle of this training, I spent a 3 year period as a Research Fellow developing the use of the polymerase chain reaction to amplify immunoglobulin and T cell receptor genes as a means of assessing minimal residual disease in the bone marrow of children with acute lymphoblastic leukaemia before and after allogeneic stem cell transplantation.
I spend much of my time treating patients with various forms of haematological cancer (i.e. acute leukaemia, lymphoma, Hodgkin's disease, chronic lymphocytic leukaemia and chronic myeloid leukaemia) but I also have a large practice seeing and advising patients on other general haematological conditions (including anaemia, low platelet counts, myeloproliferative disorders and myelodysplasia as well as common coagulation problems).
Since my appointment as a Consultant Haematologist in Bath in January 2000, I was appointed as Clinical Director for Oncology & Haematology at the Royal United Hospital, a post that I held for 10 years until October 2010.
I set up the Oncology & Haematology Clinical Governance Committee in March 2001 and led the group until November 2013 when I was appointed Clinical Governance Lead for the Division of Medicine. I resigned from this latter role in November 2018. However, I now have responsibility for maintaining effective review of patients who have died at the RUH in order to identify and disseminate any learning that may have arisen from the care that they were provided with.
I was elected Chairman of the Avon, Somerset & Wiltshire Cancer Services Haematology Site Specialist Group from December 2001 to July 2006 and still play an active role in the group.
I was a regular member of the South West Regional Cancer Drug Fund Panel from its inception in January 2011 to May 2013.
I am a member of the Panel of Examiners for the Royal College of Pathologists which is responsible for ensuring that trainees in haematology meet the minimum standards to act as a Consultant.
Areas of interest
Haematological Oncology (e.g. leukaemia, lymphoma); Myeloproliferative disorders (e.g. polycythaemia, myelofibrosis, essential thrombocythaemia); Myelodysplasia; Anaemia; Leucopenia; Thrombocytopenia; Thrombosis & anticoagulation
Medical secretaries
- Linda Vince
- BMI Bath Clinic Claverton Down Road Combe Down Bath BA2 7BR
- 01225 838861
- linda.vince@bmibathclinic.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Bath Clinic (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)
-
X3570
Therapeutic venesection - (1-5)
Bath Clinic (1-5)